| Vaccine Therapy in Treating Patients With Metastatic Breast Cancer (NCT00003761) | Dana-Farber Cancer Institute | 1999-03-03 |
| Pharmacokinetics and Safety of WAL2014 (Talsaclidine) Administered Orally to Healthy Adult Male Volunteers (NCT02264080) | Boehringer Ingelheim | 1999-03-01 |
| Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer (NCT00005023) | University of Washington | 1999-03-01 |
| Dose Escalation Study With 99mTC - or 186 Re-labelled Humanised Monoclonal Antibody (hMAb) BIWA 4 in Patients With Head and Neck Cancer (NCT02204033) | Boehringer Ingelheim | 1999-03-01 |
| Safety, Tolerability and Pharmacodynamics of BIIF 1149 BS in Healthy Young Male Volunteers (NCT02199899) | Boehringer Ingelheim | 1999-03-01 |
| Study Evaluating the Safety and Tolerability of L-377202 (NCT00987753) | University of Alabama at Birmingham | 1999-03-01 |
| Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma (NCT00004025) | Genzyme, a Sanofi Company | 1999-03-01 |
| Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy (NCT00005627) | Dana-Farber Cancer Institute | 1999-03-01 |
| Effects of Stimulant Dependence on Human Striatal Dopamine System - 15 (NCT00000350) | National Institute on Drug Abuse (NIDA) | 1999-03-01 |
| Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer (NCT00019591) | National Cancer Institute (NCI) | 1999-03-01 |
| Gene Therapy in Treating Patients With Advanced Head and Neck Cancer (NCT00009841) | University of Pittsburgh | 1999-03-01 |
| Treadmill Training With Body Weight Support in Patients With Spinal Cord Injury (NCT00061295) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1999-03-01 |
| IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma (NCT00003842) | Barrett Cancer Center | 1999-03-01 |
| Safety and Tolerability of Liraglutide in Healthy Male Volunteers (NCT01507272) | Novo Nordisk A/S | 1999-03-01 |
| Anhydrovinblastine in Treating Patients With Advanced Recurrent Solid Tumors (NCT00003882) | Roswell Park Cancer Institute | 1999-03-01 |
| Irinotecan and Capecitabine in Treating Patients With Solid Tumors (NCT00003867) | Montefiore Medical Center | 1999-03-01 |
| Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone Involvement (NCT00003902) | Swiss Cancer Institute | 1999-03-01 |
| Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma (NCT00003954) | Fred Hutchinson Cancer Center | 1999-03-01 |
| Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer (NCT00003385) | Gynecologic Oncology Group | 1999-03-01 |
| A Study Comparing Two Forms of Didanosine in HIV-infected Patients (NCT00002360) | Bristol-Myers Squibb | 1999-03-01 |
| Trastuzumab and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer (NCT00009997) | NYU Langone Health | 1999-03-01 |
| Gene Therapy in Treating Patients With Recurrent Malignant Gliomas (NCT00004041) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1999-02-25 |
| Lurtotecan Liposome in Treating Patients With Advanced Solid Tumors (NCT00003891) | NCIC Clinical Trials Group | 1999-02-25 |
| MG98 in Treating Patients With Advanced Solid Tumors (NCT00003890) | NCIC Clinical Trials Group | 1999-02-22 |
| BIBX 1382 in Treating Patients With Solid Tumors (NCT00003980) | European Organisation for Research and Treatment of Cancer - EORTC | 1999-02-01 |
| Pharmacokinetics of Talsaclidine After Administration to Healthy Subjects (NCT02264054) | Boehringer Ingelheim | 1999-02-01 |
| Monoclonal Antibody Therapy in Treating Patients With Refractory Anaplastic Large Cell Lymphoma or Hodgkin's Lymphoma (NCT00003741) | Beth Israel Deaconess Medical Center | 1999-02-01 |
| Ifosfamide, Teniposide, and Paclitaxel in Treating Patients With Relapsed Non-Hodgkin's Lymphoma (NCT00004916) | Northwestern University | 1999-02-01 |
| Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia (NCT00003874) | Fred Hutchinson Cancer Center | 1999-02-01 |
| IM-862 in Treating Patients With Recurrent Ovarian Cancer (NCT00003773) | University of Southern California | 1999-02-01 |
| Effects of Exendin(9-39) on Gastroduodenal Motility (NCT00468091) | Ludwig-Maximilians - University of Munich | 1999-02-01 |
| Phase I Study of Alpha-Melanocyte Stimulating Hormone in Patients With Acute Renal Failure (NCT00004496) | University of Texas | 1999-02-01 |
| Influence of Clopidogrel on the Pharmacodynamics and Safety of Terbogrel in Healthy Male Subjects (NCT02222987) | Boehringer Ingelheim | 1999-02-01 |
| Clofarabine in Chronic Lymphocytic Leukemia (NCT00028418) | M.D. Anderson Cancer Center | 1999-02-01 |
| Movement Disorders Caused by Antipsychotic Drugs in Older Patients (NCT00255879) | University of California, San Diego | 1999-01-01 |
| Influence of Clopidogrel on the Pharmacodynamics and Safety of Fradafiban in Healthy Male Subjects (NCT02265289) | Boehringer Ingelheim | 1999-01-01 |
| Gene Therapy Plus Chemotherapy in Treating Patients With Breast Cancer (NCT00004038) | National Cancer Institute (NCI) | 1999-01-01 |
| Chemotherapy in Treating Patients With Advanced Solid Tumors (NCT00003703) | Jewish General Hospital | 1999-01-01 |
| Chemotherapy and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer (NCT00022308) | Fox Chase Cancer Center | 1999-01-01 |
| Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma (NCT00003970) | National Cancer Institute (NCI) | 1999-01-01 |
| Single Increasing Dose Tolerance Study in Healthy Male Volunteers of BIIR 561 CL (NCT02222974) | Boehringer Ingelheim | 1999-01-01 |
| Dose Extension Study of BIIX 1 XX in Healthy Young Male Volunteers (NCT02198287) | Boehringer Ingelheim | 1999-01-01 |
| Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors (NCT00003899) | Fred Hutchinson Cancer Center | 1999-01-01 |
| Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Melanoma (NCT00003552) | National Heart, Lung, and Blood Institute (NHLBI) | 1999-01-01 |
| Treatment of Osteonecrosis of the Femoral Head by Bone Marrow Transplantation (NCT00821470) | Erasme University Hospital | 1999-01-01 |
| Trial for Evaluation of Safety of Escalating Dose Levels of MEDI-507 in Patients for Treatment of at Least Grade II Graft-Versus-Host Disease (GvHD) (NCT00806208) | MedImmune LLC | 1999-01-01 |
| Vaccine Therapy in Treating Patients With Melanoma (NCT00003556) | National Cancer Institute (NCI) | 1999-01-01 |
| Study to Evaluate the Effects of Underlying Renal or Hepatic Dysfunction on the Pharmacokinetics of Nevirapine (NCT02184091) | Boehringer Ingelheim | 1999-01-01 |
| Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism (NCT00493961) | Massachusetts General Hospital | 1999-01-01 |
| Dolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia (NCT00003693) | M.D. Anderson Cancer Center | 1998-12-18 |
| Vaccination Priming and Vaccine Boosting Trial of Allogeneic Human GM-CSF Gene Transduced Irradiated Prostate Cancer Cell Vaccines (GVAX® Vaccine for Prostate Cancer) (NCT00140374) | Cell Genesys | 1998-12-01 |
| Transcranial Magnetic Stimulation for the Treatment of Phantom Pain (NCT00001923) | National Institute of Neurological Disorders and Stroke (NINDS) | 1998-12-01 |
| Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors (NCT00003690) | Mayo Clinic | 1998-12-01 |
| Enteric Oxalate Absorption Study in Unclassified Hyperoxaluria (NCT00588120) | Mayo Clinic | 1998-12-01 |
| Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant (NCT00107354) | Fred Hutchinson Cancer Center | 1998-12-01 |
| Combination Iron Chelation Therapy (NCT00004982) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1998-12-01 |
| 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder (NCT00004058) | University of Medicine and Dentistry of New Jersey | 1998-12-01 |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma (NCT00003625) | Children's Oncology Group | 1998-12-01 |
| Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphomas (NCT00004057) | Memorial Sloan Kettering Cancer Center | 1998-12-01 |
| Immunotoxin Therapy in Treating Patients With Hairy Cell Leukemia (NCT00021983) | National Cancer Institute (NCI) | 1998-12-01 |
| Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer (NCT00003102) | Ludwig Institute for Cancer Research | 1998-11-17 |
| Gene Therapy in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Surgically Removed (NCT00003649) | Eastern Cooperative Oncology Group | 1998-11-17 |
| Relative Bioavailability of Epinastine Syrup Compared to Tablets in Healthy Volunteers (NCT02260063) | Boehringer Ingelheim | 1998-11-01 |
| Stereotactic Radiosurgery in Treating Patients With Brain Tumors (NCT00019578) | National Institutes of Health Clinical Center (CC) | 1998-11-01 |
| Bioavailability, Pharmacokinetics and Safety of ESR 1150 CL in Healthy Adult Male Volunteers (NCT02183259) | Boehringer Ingelheim | 1998-11-01 |
| Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors (NCT00003597) | Children's Oncology Group | 1998-11-01 |
| Pharmacodynamics, Safety and Pharmacokinetics After Oral Administration of BIBR 1048 MS in Healthy Volunteers (NCT02170116) | Boehringer Ingelheim | 1998-11-01 |
| Single Dose Pharmacokinetics of Prucalopride in Paediatric Subjects, With Functional Faecal Retention (NCT01674166) | Movetis | 1998-11-01 |
| Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer (NCT00003411) | University of Pittsburgh | 1998-11-01 |
| Combinations of Pharmacologic Smoking Cessation Treatments (NCT00018187) | US Department of Veterans Affairs | 1998-11-01 |
| Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors (NCT00003926) | Masonic Cancer Center, University of Minnesota | 1998-11-01 |
| Pharmacokinetics and Tolerability of Meloxicam Injected Intramuscularly vs. Tablet in Healthy Subjects (NCT02183090) | Boehringer Ingelheim | 1998-11-01 |
| Chemotherapy in Treating Patients With Advanced Solid Tumors (NCT00003721) | The University of Texas Health Science Center at San Antonio | 1998-11-01 |
| The Effect of Alcoholic-carrier Solutions Within Devices (HFA134a-MDI or Respimat®) on Breath Alcohol Measured by Ethylometer in Healthy Volunteers (NCT02264145) | Boehringer Ingelheim | 1998-11-01 |
| Prucalopride in Paediatric Subjects, With Functional Faecal Retention (NCT01670669) | Movetis | 1998-11-01 |
| Monoclonal Antibody F19 in Treating Patients With Advanced or Metastatic Cancer (NCT00004042) | Memorial Sloan Kettering Cancer Center | 1998-11-01 |
| Arsenic Trioxide in Treating Patients With Refractory or Recurrent Acute Promyelocytic Leukemia (NCT00008697) | Washington University School of Medicine | 1998-11-01 |
| Lepirudin in Treating Patients With Recurrent or Advanced Small Cell Lung Cancer (NCT00003726) | Dartmouth-Hitchcock Medical Center | 1998-11-01 |
| Gene Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma (NCT00003942) | Systemix | 1998-11-01 |
| Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma (NCT00003616) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1998-10-22 |
| To Demonstrate the Relative Bioavailability of Bupropion HCI 100 mg Tablets Under Fasting Conditions (NCT00883155) | Sandoz | 1998-10-01 |
| Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma (NCT00003747) | Mount Vernon Cancer Centre at Mount Vernon Hospital | 1998-10-01 |
| Bioavailability Study of Famotidine Tablets 40 mg Under Fasting Conditions (NCT01511731) | Dr. Reddy's Laboratories Limited | 1998-10-01 |
| Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia (NCT00001790) | National Cancer Institute (NCI) | 1998-10-01 |
| Combination Chemotherapy in Treating Patients With Advanced Cancer (NCT00003707) | The University of Texas Health Science Center at San Antonio | 1998-10-01 |
| Ro 31-7453 in Treating Patients With Locally Advanced or Metastatic Solid Tumor (NCT00003755) | Memorial Sloan Kettering Cancer Center | 1998-10-01 |
| Tolerability and Pharmacokinetics of Lacidipine With and Without the Co-administration of Telmisartan in Female and Male Healthy Subjects (NCT02203500) | Boehringer Ingelheim | 1998-10-01 |
| Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors (NCT00003742) | Memorial Sloan Kettering Cancer Center | 1998-10-01 |
| Chemotherapy in Treating Patients With Advanced Solid Tumors (NCT00003709) | The University of Texas Health Science Center at San Antonio | 1998-10-01 |
| Brown Seaweed as a Breast Cancer Preventive (NCT01204957) | University of South Carolina | 1998-10-01 |
| Dose Tolerance Study After Ocular Administration of Tiotropium in Healthy Male Volunteers (NCT02177305) | Boehringer Ingelheim | 1998-10-01 |
| PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy (NCT00019565) | National Institutes of Health Clinical Center (CC) | 1998-10-01 |
| Study of Irinotecan on a Weekly Schedule in Children (NCT00062842) | Baylor College of Medicine | 1998-09-09 |
| Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme (NCT00003417) | Radiation Therapy Oncology Group | 1998-09-01 |
| Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer (NCT00003877) | Roswell Park Cancer Institute | 1998-09-01 |
| Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's Lymphoma (NCT00005580) | Virginia Commonwealth University | 1998-09-01 |
| Bioavailability of Ibuprofen Enantiomers Compared With Standard Brufen Sirup in Healthy Male Volunteers (NCT02182960) | Boehringer Ingelheim | 1998-09-01 |
| Telmisartan/Hydrochlorothiazide (HCTZ) Fixed Dose Combination Compared to Its Monocomponents in Healthy Subjects (NCT02176512) | Boehringer Ingelheim | 1998-09-01 |
| Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome (NCT00005593) | Case Comprehensive Cancer Center | 1998-09-01 |
| Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal Cancer (NCT00003450) | University of Texas Southwestern Medical Center | 1998-09-01 |